Dr Clay Siegall has been continuously contributing to the ongoing fight against one of the worst diseases known to humankind – cancer. He has been conducting medical research for many years, seeking to help combat the silent killer.
Dr Clay Siegall received his education from the George Washington University and graduated with a PH. D. in Genetics. After that, he spent a few years conducting medical research at the Bristol – Myers Squibb Pharmaceutical Research Institute. He was Senior Research Investigator at the Institute but was later offered the position of Principal Scientists which he accepted. After some years of contributing and showing his excellent skills as a leader, Dr Clay Siegall moved on from the Research Institute. He became a valuable part of the National Cancer Institute where he developed his research further under the position of Staff Fellow. And later as Biotechnology fellow.
In early 1998, Dr Clay Siegall decided to establish a research company that will be dedicated to the fight against cancer and further medical studies in the area. He founded Seattle Genetics which experienced great success and became the developer of the first ADCs which stands for antibody – drug conjugates. Seattle Genetics was also the developer of ADCETRIS® which is a brentuximab vedotin. This medication was approved by the FDA during 2011 and can be found in more than sixty countries. As a whole, Dr Clat Siegall is the owner of more than fifteen patents.
In 2013, Dr Clay Siegall received the coveted recognition os the University of Maryland. He was awarded the title of Alumnus of the Year for Computer, Math and Natural Sciences. This title is given to doctors and scientists who have achieved great heights in their respective fields of practice and research.
Dr Clay Siegall has been very involved with taking care of his company. He fundraised more than two billion dollars to aid Seattle Genetics and to enable further research and drug development.
In his spare time, Dr Clay Siegall likes to catch up on the latest news from the worlds of science and medicine of any field. He shares the latest findings on his personal blog.